研究论文
Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux)
Meyer‐Michel Samama, Grigoris Gerotziafas
Hôtel-Dieu de Paris
来源Thrombosis Research
年份2003
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
630
617
18
19
20
21
22
23
24
25
26
关键指标
164
被引次数 · OpenAlex
8.84
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 2%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
58
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Venous Thromboembolism Diagnosis and Management
Atrial Fibrillation Management and Outcomes · Heparin-Induced Thrombocytopenia and Thrombosis
参考文献 58
Absence of Placental Transfer of Pentasaccharide (Fondaparinux, Arixtra®) in the Dually Perfused Human Cotyledon in vitro
被引 102C. Vergnes, J.L. Brun, F Paolucci · Thrombosis and Haemostasis · 2002
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
被引 1,327Rory Collins, Alison Scrimgeour, Salim Yusuf · New England Journal of Medicine · 1988
Efficacy of a Synthetic Pentasaccharide, a Pure Factor Xa Inhibitor, as an Antithrombotic Agent – A Pilot Study in the Setting of Coronary Angioplasty
被引 73Alain Vuillemenot, François Schiele, Nicolas Meneveau · Thrombosis and Haemostasis · 1999
此处列出前 3 条
引用本文 164
Heparin and Low-Molecular-Weight Heparin
被引 1,033Jack Hirsh, Theodore E. Warkentin, Robert Raschke · CHEST Journal · 1998
Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor
被引 655Dagmar Kubitza, Michael Becka, Barbara Voith · Clinical Pharmacology & Therapeutics · 2005
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
被引 610Nirmala Raghavan, Charles Frost, Zhigang Yu · Drug Metabolism and Disposition · 2008
按被引量排序，此处列出前 3 条